Today: 21 May 2026
Browse Category

HOSE:VIC 25 September 2025 - 7 March 2026

Ho Chi Minh Stock Exchange Last Week: VN-Index Sinks Below 1,800 in Broad Selloff

Ho Chi Minh Stock Exchange Last Week: VN-Index Sinks Below 1,800 in Broad Selloff

Vietnam’s VN-Index fell nearly 6% to 1,767.84 for the week ending March 6, with a 2.25% drop on Friday. Foreign investors sold a net 1.306 trillion dong on HoSE, hitting large caps like FPT and VIC. The selloff followed global market declines after Middle East conflict pushed oil higher. Despite the slide, foreign direct investment rose 8.8% to $3.21 billion in early 2026.
Vietnam stocks week ahead: Ho Chi Minh VN-Index faces a settlement test after T+2 glitch

Vietnam stocks week ahead: Ho Chi Minh VN-Index faces a settlement test after T+2 glitch

Ho Chi Minh Stock Exchange will reopen Monday after a KRX system maintenance delay disrupted some T+2 settlements late last week. The VN-Index closed Friday at 1,880.33, up 0.04%, while the VN30 index fell 0.39%. Settlement issues were resolved by Friday afternoon, according to state media. Traders await Monday’s manufacturing PMI and key February economic data later in the week.
Vietnam stocks: Ho Chi Minh Stock Exchange VN-Index ends February up as settlement snag puts March in focus

Vietnam stocks: Ho Chi Minh Stock Exchange VN-Index ends February up as settlement snag puts March in focus

VN-Index closed at 1,880.33 on Friday, up 3.1% for the week, as foreign investors turned net buyers and fertilizer and oil-and-gas stocks led gains. Trading volume reached about 858 million shares, with turnover at 33.4 trillion dong. Brokerages briefly halted some settlements after a delay at the Vietnam Securities Depository, but the system was restored by mid-afternoon. Traders await March 2 PMI and March 6 macro data.
Asia Markets Whipsaw: Japan’s Record Rally, China Tech Soars on AI, Scandal Rocks Manila (Sep 24–25, 2025)

Asia Markets Whipsaw: Japan’s Record Rally, China Tech Soars on AI, Scandal Rocks Manila (Sep 24–25, 2025)

Japan’s Nikkei 225 closed at a record ¥45,755 on Sep 25, up 0.3%, as investors shifted into lagging stocks. Hong Kong’s Hang Seng jumped 1.4% and Alibaba surged nearly 9% after a major AI investment. India’s Sensex slid 0.5% on U.S. visa fee news and foreign outflows. The Philippines’ PSE index dropped 1% to a six-month low amid a corruption scandal and weak peso.

Stock Market Today

  • Analyst Revises MongoDB Outlook After Sharp 22% Stock Decline
    May 20, 2026, 11:08 PM EDT. An analyst shifted to a more favorable view on MongoDB (NASDAQ: MDB) after its stock plunged 22% on March 3, 2026, despite better-than-expected fiscal Q4 results. The company reported $695 million revenue, up 27% year-over-year, with Atlas cloud revenue hitting a $2 billion annual run rate. However, cautious fiscal 2027 guidance projecting 16-18% revenue growth-below expectations-triggered the drop and a Baird price target cut from $500 to $260. The analyst now highlights MongoDB's strong business fundamentals, including a 23% adjusted operating margin and leading position in document databases, which support cloud-native applications. The initial high valuation and AI premium correction have shifted risk perceptions, revealing a steadier business amid recent market volatility.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop